We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.4B
AUM Growth
-$489M
Cap. Flow
+$10.4M
Cap. Flow %
0.12%
Top 10 Hldgs %
15.04%
Holding
758
New
34
Increased
325
Reduced
263
Closed
36

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$67.6M
2
SPGI icon
S&P Global
SPGI
+$31.4M
3
VYX icon
NCR Voyix
VYX
+$27.7M
4
CABO icon
Cable One
CABO
+$24.5M
5
CRL icon
Charles River Laboratories
CRL
+$19.8M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Healthcare 17.75%
3 Industrials 16.27%
4 Financials 13.04%
5 Consumer Discretionary 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WNS
101
DELISTED
WNS Holdings
WNS
$25.1M 0.3%
306,594
+90,459
+42% +$7.51M
GMED icon
102
Globus Medical
GMED
$10.7B
$24.5M 0.29%
411,775
+53,729
+15% +$3.24M
PPBI
103
DELISTED
Pacific Premier Bancorp
PPBI
$24.1M 0.29%
778,169
+17,656
+2% +$575K
NEE icon
104
NextEra Energy
NEE
$181B
$23.9M 0.28%
304,417
+140
+0% +$11.9K
WRB icon
105
W.R. Berkley
WRB
$26.9B
$23.8M 0.28%
553,620
+114,699
+26% +$4.98M
AIR icon
106
AAR Corp
AIR
$5.59B
$23.7M 0.28%
662,273
+26,756
+4% +$1.14M
ASTE icon
107
Astec Industries
ASTE
$1.16B
$23.2M 0.28%
745,058
+19,437
+3% +$790K
NX icon
108
Quanex
NX
$819M
$23M 0.27%
1,264,927
+34,946
+3% +$790K
DG icon
109
Dollar General
DG
$28B
$23M 0.27%
95,737
+52,420
+121% +$12.9M
CIR
110
DELISTED
CIRCOR International, Inc
CIR
$22.6M 0.27%
1,370,392
+46,697
+4% +$776K
ABBV icon
111
AbbVie
ABBV
$443B
$22.5M 0.27%
167,978
-1,201
-0.7% -$172K
PANW icon
112
Palo Alto Networks
PANW
$270B
$22.4M 0.27%
273,580
-1,472
-0.5% -$127K
FARO
113
DELISTED
Faro Technologies
FARO
$22M 0.26%
803,532
-25,857
-3% -$843K
HP icon
114
Helmerich & Payne
HP
$3.45B
$21.6M 0.26%
585,187
+23,385
+4% +$984K
GPK icon
115
Graphic Packaging
GPK
$3.17B
$21.6M 0.26%
1,095,480
+286,070
+35% +$6.28M
BCRX icon
116
BioCryst Pharmaceuticals
BCRX
$2.28B
$21.2M 0.25%
1,681,189
-142,020
-8% -$1.83M
RRC icon
117
Range Resources
RRC
$9.38B
$20.8M 0.25%
822,945
+171,203
+26% +$5.18M
WSBC icon
118
WesBanco
WSBC
$3.97B
$20.6M 0.24%
615,998
+17,693
+3% +$601K
CPRI icon
119
Capri Holdings
CPRI
$1.83B
$20.5M 0.24%
533,384
-27,795
-5% -$1.3M
ASML icon
120
ASML
ASML
$626B
$20.4M 0.24%
49,201
-1,863
-4% -$933K
CBU icon
121
Community Bank
CBU
$3.41B
$20M 0.24%
333,644
+7,604
+2% +$501K
P
122
Everpure Inc
P
$25.7B
$20M 0.24%
730,714
+86,883
+13% +$2.46M
CUZ icon
123
Cousins Properties
CUZ
$5.19B
$19.3M 0.23%
825,822
-103,403
-11% -$2.92M
TRNO icon
124
Terreno Realty
TRNO
$7.57B
$19.2M 0.23%
362,222
+217,074
+150% +$13.1M
AGI icon
125
Alamos Gold
AGI
$11.6B
$19M 0.23%
2,564,664
+817,974
+47% +$6.05M

Similar funds

Segall Bryant & Hamill's Q3 2022 Portfolio in Review

As of Q3 2022, Segall Bryant & Hamill held 758 positions worth $8.4B, down 5.5% from $8.88B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q3 2022 filing shows 34 new, 325 increased, 263 reduced and 36 closed positions. Its largest new stake was Ollie's Bargain Outlet: 570,889 shares worth $29.5M. The largest sale was Adobe, an estimated $67.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Segall Bryant & Hamill's largest Q3 2022 buy was Ollie's Bargain Outlet: 570,889 shares worth $29.5M.
  • Segall Bryant & Hamill added most to Novo Nordisk in Q3 2022, an estimated $27.4M increase.
  • Segall Bryant & Hamill's biggest Q3 2022 reduction was Adobe, cutting an estimated $67.6M.
  • Segall Bryant & Hamill fully exited Beacon Roofing Supply, Inc. in Q3 2022, selling an estimated $11.9M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $8.4B portfolio in Q3 2022.
  • Segall Bryant & Hamill opened 34 new positions and closed 36 in Q3 2022.
  • Segall Bryant & Hamill's portfolio value fell 5.5% quarter-over-quarter to $8.4B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2022, filed 14 Nov 2022.